Cargando…
Vitamin D levels do not cause vitamin-drug interactions with dexamethasone or dasatinib in mice
Vitamin D(3) (VD(3)) induces intestinal CYP3A that metabolizes orally administered anti-leukemic chemotherapeutic substrates dexamethasone (DEX) and dasatinib potentially causing a vitamin-drug interaction. To determine the impact of VD(3) status on systemic exposure and efficacy of these chemothera...
Autores principales: | Annu, Kavya, Yasuda, Kazuto, Caufield, William V., Freeman, Burgess B., Schuetz, Erin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528301/ https://www.ncbi.nlm.nih.gov/pubmed/34669728 http://dx.doi.org/10.1371/journal.pone.0258579 |
Ejemplares similares
-
Role of Vitamins A and D in BCR-ABL Arf(−/−) Acute Lymphoblastic Leukemia
por: Annu, Kavya, et al.
Publicado: (2020) -
Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors)
por: Krasowski, Matthew D, et al.
Publicado: (2005) -
Haemorrhagic Colitis Caused by Dasatinib
por: Patodi, Nishant, et al.
Publicado: (2012) -
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
por: Wieduwilt, Matthew J., et al.
Publicado: (2021) -
Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats
por: Shahid, Mudassar, et al.
Publicado: (2023)